Dr. Annabel  Wang   image

Dr. Annabel Wang

5 East 98 St 7Th Floor
New York NY 10029
212 417-7076
Medical School: Other - Unknown
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: No
Participates In EHR: No
License #: 212324
NPI: 1831169143
Taxonomy Codes:
2084N0008X 2084N0400X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy


Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found


None Found


Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. - Annals of human genetics
Recent genome-wide single nucleotide polymorphism (SNP) association studies (GWAS) have identified a number of SNPs that were significantly associated with coronary artery disease and myocardial infarction (MI). However, many independent replication studies in other populations are needed to unequivocally confirm the GWAS association. To assess GWAS association, we have established a case-control cohort consisting of 1231 well-characterised MI patients and 560 controls without detectable coronary stenosis, all selected from the Cleveland Genebank population. The Genebank cohort has sufficient power to detect the association between MI and four GWAS SNPs, including rs17465637 within the MIA3 gene, rs2943634 (intergenic), rs6922269 in MTHFD1L, and rs599839 near SORT1. SNPs were genotyped by TaqMan assays and follow-up multivariate logistic regression analysis with incorporation of significant covariates showed significant association with MI for MIA3 SNP rs17465637 (P-adj= 0.0034) and SORT1 SNP rs599839 (P-adj= 0.009). The minor allele G of rs599839 was also associated with a decreased LDL-C level of 5-9 mg/dL per allele, but not with HDL-C or triglyceride levels. No association for MI or lipid levels was found for SNPs rs2943634 and rs6922269 (P-adj > 0.05). Our results establish two SNPs, rs17465637 in MIA3 and rs599839 near SORT1 as significant risk factors for MI in the American Genebank Caucasian population.© 2011 Cleveland Clinic Annals of Human Genetics © 2011 Blackwell Publishing Ltd/University College London.
Do A-waves help predict intravenous immunoglobulin response in multifocal motor neuropathy without block? - Muscle & nerve
Are there electrophysiological findings that predict response to intravenous immunoglobulin (IVIg) in patients with lower motor neuron (LMN) syndromes without multifocal conduction block (MCB)?We enrolled 9 patients with LMN syndromes without MCB to receive 18 weeks of IVIg therapy. Response was measured at weeks 2 and 18 using the Appel Amyotrophic Lateral Sclerosis (AALS) score (includes grip and pincer strength measures), ALS Functional Rating Scale (ALSFRS), and electrophysiological measures, including motor unit estimates (MUNEs).No change occurred in AALS or ALSFRS scores posttreatment. Grip/pincer strength increased in 7 patients (P = 0.028) after initial treatment (responders); 2 showed no improvement (non-responders). No electrophysiological measure changed after treatment in either group but MUNEs trended higher (P = 0.055). "Abnormal A-waves" (complex, repetitive biphasic, or present in multiple nerves) occurred in pretreatment studies more often in responders (P = 0.028)."Abnormal A-waves" may signal IVIg-responsive LMN syndromes even if conduction block is absent.Copyright © 2011 Wiley Periodicals, Inc.
Patterns of neuropathy and autonomic failure in patients with amyloidosis. - Mayo Clinic proceedings
To define the clinical patterns of peripheral neuropathy and autonomic testing abnormalities in patients with amyloidosis.A retrospective chart review was conducted of 65 patients who had biopsy-proven amyloidosis and autonomic function testing between January 1, 1985, and December 31, 1997, at Mayo Clinic's site in Rochester, MN. Patients were required to have neurologic evaluation, autonomic reflex screening, and tissue confirmation of amyloidosis.We identified 5 clinical patterns of peripheral neuropathy: (1) generalized autonomic failure and polyneuropathy with pain (40 patients [62%]), (2) generalized autonomic failure and polyneuropathy without pain (11 [17%]), (3) isolated generalized autonomic failure (7 [11%]), (4) polyneuropathy without generalized autonomic failure (4 [6%]), and (5) generalized autonomic failure and small-fiber (ie, autonomic and somatic C-fiber) neuropathy (3 [5%]). Moderately severe generalized autonomic failure, involving adrenergic, cardiovagal, or sudomotor domains, was found in all patients, including those without clinically manifested autonomic failure. The diagnosis of amyloidosis was delayed in patients who did not have initial symptoms of pain or generalized autonomic failure (48 months to diagnosis in patients with polyneuropathy without autonomic failure vs 12 months to diagnosis in patients with autonomic failure and small-fiber neuropathy; P=.57).Physicians should test for symptoms of generalized autonomic failure in patients who have peripheral neuropathy of unknown origin. Autonomic testing may give abnormal results in patients without overt symptoms of autonomic failure. Early recognition of autonomic failure may lead to earlier diagnosis of the underlying pathogenesis of amyloidosis, as well as earlier treatment for patients with this condition.

Map & Directions

5 East 98 St 7Th Floor New York, NY 10029
View Directions In Google Maps

Nearby Doctors

1 Gustave L Levy Pl # 1272 Mount Sinai School Of Medicine / Urology Dept
New York, NY 10029
212 414-4812
1901 1St Ave Rm. 10M-1
New York, NY 10029
212 237-7052
5 E 98Th St # 1188
New York, NY 10029
212 411-1621
One Gustave Levy Place Mount Sinai Hospital Box 1230
New York, NY 10029
212 599-9145
5 East 98Th Street 11Th Floor Mount Sinai Medical Ctr (Faculty Practice Assoc/Fpa)
New York, NY 10029
212 417-7270
5 E 98Th St Box 1188
New York, NY 10029
212 411-1621
1 Gustave L Levy Pl Box 3000
New York, NY 10029
212 873-3100
1391 Madison Ave Apt 5F
New York, NY 10029
212 414-4029
5 E 98Th St 6Th Floor
New York, NY 10029
212 416-6389